Biological aspects in controlling angiogenesis: current progress

被引:38
作者
Akbarian, Mohsen [1 ]
Bertassoni, Luiz E. [2 ]
Tayebi, Lobat [3 ]
机构
[1] Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan
[2] Oregon Hlth & Sci Univ, Sch Dent, Dept Restorat Dent, Div Biomat & Biomech, Portland, OR 97201 USA
[3] Marquette Univ, Sch Dent, Milwaukee, WI 53233 USA
基金
美国国家卫生研究院;
关键词
Angiogenesis; Pro-angiogenics; Anti-angiogenics; Vascularization; Tissue engineering; ENDOTHELIAL GROWTH-FACTOR; VASCULAR GENE-EXPRESSION; PLANT ANTITUMOR AGENTS; MINIMAL ACTIVE DOMAIN; IN-VITRO; MOLECULAR-MECHANISMS; ANTIANGIOGENIC THERAPY; TUMOR-GROWTH; CELL-PROLIFERATION; VEGF-A;
D O I
10.1007/s00018-022-04348-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
All living beings continue their life by receiving energy and by excreting waste products. In animals, the arteries are the pathways of these transfers to the cells. Angiogenesis, the formation of the arteries by the development of pre-existed parental blood vessels, is a phenomenon that occurs naturally during puberty due to certain physiological processes such as menstruation, wound healing, or the adaptation of athletes' bodies during exercise. Nonetheless, the same life-giving process also occurs frequently in some patients and, conversely, occurs slowly in some physiological problems, such as cancer and diabetes, so inhibiting angiogenesis has been considered to be one of the important strategies to fight these diseases. Accordingly, in tissue engineering and regenerative medicine, the highly controlled process of angiogenesis is very important in tissue repairing. Excessive angiogenesis can promote tumor progression and lack of enough angiogensis can hinder tissue repair. Thereby, both excessive and deficient angiogenesis can be problematic, this review article introduces and describes the types of factors involved in controlling angiogenesis. Considering all of the existing strategies, we will try to lay out the latest knowledge that deals with stimulating/inhibiting the angiogenesis. At the end of the article, owing to the early-reviewed mechanical aspects that overshadow angiogenesis, the strategies of angiogenesis in tissue engineering will be discussed.
引用
收藏
页数:35
相关论文
共 338 条
[1]   Effect of diabetes mellitus on formation of coronary collateral vessels [J].
Abaci, A ;
Oguzhan, A ;
Kahraman, S ;
Eryol, NK ;
Ünal, S ;
Arinç, H ;
Ergin, A .
CIRCULATION, 1999, 99 (17) :2239-2242
[2]   Molecular regulation of angiogenesis and lymphangiogenesis [J].
Adams, Ralf H. ;
Alitalo, Kari .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) :464-478
[4]   The FLASH effect depends on oxygen concentration [J].
Adrian, Gabriel ;
Konradsson, Elise ;
Lempart, Michael ;
Back, Sven ;
Ceberg, Crister ;
Petersson, Kristoffer .
BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1106)
[5]   Role of vascular endothelial growth factor in diabetic vascular complications [J].
Aiello, LP ;
Wong, JS .
KIDNEY INTERNATIONAL, 2000, 58 :S113-S119
[6]   AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1 [J].
Akeson, AL ;
Woods, CW ;
Hsieh, LC ;
Bohnke, RA ;
Ackermann, BL ;
Chan, KY ;
Robinson, JL ;
Yanofsky, SD ;
Jacobs, JW ;
Barrett, RW ;
Bowlin, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30517-30523
[7]   Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review [J].
Al-Abd, Ahmed M. ;
Alamoudi, Abdulmohsin J. ;
Abdel-Naim, Ashraf B. ;
Neamatallah, Thikryat A. ;
Ashour, Osama M. .
JOURNAL OF ADVANCED RESEARCH, 2017, 8 (06) :591-605
[8]   Antiangiogenic Therapy for Cancer: An Update [J].
Al-Husein, Belal ;
Abdalla, Maha ;
Trepte, Morgan ;
DeRemer, David L. ;
Somanath, Payaningal R. .
PHARMACOTHERAPY, 2012, 32 (12) :1095-1111
[9]  
Albert Stephen, 2002, Clin Podiatr Med Surg, V19, P483, DOI 10.1016/S0891-8422(02)00018-6
[10]   Curcumin is an in vivo inhibitor of angiogenesis [J].
Arbiser, JL ;
Klauber, N ;
Rohan, R ;
van Leeuwen, R ;
Huang, MT ;
Fisher, C ;
Flynn, E ;
Byers, HR .
MOLECULAR MEDICINE, 1998, 4 (06) :376-383